Literature DB >> 10980964

Microecologic approaches for traveler's diarrhea, antibiotic-associated diarrhea, and acute pediatric diarrhea.

L V McFarland1.   

Abstract

Bacterial and viral diarrhea remain important causes of morbidity and mortality throughout the world. Current concerns with medical costs, increasing frequency of antibiotic resistance, and overuse of antibiotics in general have redirected therapeutic approaches for diarrhea from traditional drugs to the use of living therapeutic organisms. Awareness of the important role of normal flora in the microecology of the intestines in fighting infection, along with the recent availability of well-controlled clinical trials for these agents, has brought microecologic therapies to the forefront of clinical practice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10980964     DOI: 10.1007/s11894-999-0113-4

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  51 in total

1.  Why America must care about tropical medicine: threats to global health and security from tropical infectious diseases.

Authors:  R L Guerrant
Journal:  Am J Trop Med Hyg       Date:  1998-07       Impact factor: 2.345

Review 2.  Epidemiology, risk factors and treatments for antibiotic-associated diarrhea.

Authors:  L V McFarland
Journal:  Dig Dis       Date:  1998 Sep-Oct       Impact factor: 2.404

Review 3.  Global progress in the control of diarrheal diseases.

Authors:  M Claeson; M H Merson
Journal:  Pediatr Infect Dis J       Date:  1990-05       Impact factor: 2.129

4.  Influence of antibiotics on the recovery and kinetics of Saccharomyces boulardii in rats.

Authors:  A V Boddy; G W Elmer; L V McFarland; R H Levy
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

5.  [Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study].

Authors:  H Kollaritsch; H Holst; P Grobara; G Wiedermann
Journal:  Fortschr Med       Date:  1993-03-30

6.  Oral bacteriotherapy for viral gastroenteritis.

Authors:  E Isolauri; M Kaila; H Mykkänen; W H Ling; S Salminen
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

7.  Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants.

Authors:  J P Buts; G Corthier; M Delmee
Journal:  J Pediatr Gastroenterol Nutr       Date:  1993-05       Impact factor: 2.839

8.  [Treatment of persistent diarrhea with S. boulardii in returning travelers. Results of a prospective study].

Authors:  A Kirchhelle; N Frühwein; D Tobüren
Journal:  Fortschr Med       Date:  1996-04-20

Review 9.  Fluoroquinolones and bacterial enteritis, when and for whom?

Authors:  J Wiström; S R Norrby
Journal:  J Antimicrob Chemother       Date:  1995-07       Impact factor: 5.790

Review 10.  Prevention and treatment of traveler's diarrhea: a clinical pharmacological approach.

Authors:  C Scarpignato; P Rampal
Journal:  Chemotherapy       Date:  1995       Impact factor: 2.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.